5//SEC Filing
HALOZYME THERAPEUTICS INC 5
Accession 0001181431-05-007924
$HALOCIK 0001159036operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:40 PM ET
Size
8.1 KB
Accession
0001181431-05-007924
Insider Transaction Report
Form 5
Engler Robert
Director
Transactions
- Award
Options to Purchase Common Stock
2004-10-13$2.05/sh+75,000$153,750→ 75,000 totalExercise: $2.05From: 2004-10-13Exp: 2014-10-13→ Common Stock (75,000 underlying) - Award
Options to Purchase Common Stock
2004-05-21$4.10/sh+150,000$615,000→ 150,000 totalExercise: $4.10From: 2004-06-21Exp: 2014-05-21→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Options vest monthly over a period of 36 months, contingent upon continued participation as a member of the Board of Directors of Issuer.
- [F2]Options vest over a period of 6 months, with 50% vesting on date of grant, and remainder vesting monthly, contingent upon continued participation as a member of the Board of Directors of Issuer.
Documents
Issuer
HALOZYME THERAPEUTICS INC
CIK 0001159036
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001159036
Filing Metadata
- Form type
- 5
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:40 PM ET
- Size
- 8.1 KB